- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03680170
Cognitive Training in Parkinson's Disease, the iPARK Study (iPARK)
The Effect of Home-based Working Memory Updating Training on Cognition and Health in Patients With Parkinson's Disease
The aim of the iPARK-study is to investigate the effects of a process-based cognitive training program with focus on working memory in patients with Parkinson's Disease (PD). The study is a double blinded, randomized controlled trial with a parallel group design that aim to recruit 80 persons with PD. All patients will undergo 30 sessions (6-7 weeks) of web-based cognitive training performed at home. The working memory training is a process-based training program focusing specific on updating. The placebo program is a low dose short term memory paradigm without updating. A battery of neuropsychological tests (working memory, attention, episodic memory, inhibition control, risk taking and motoric speed) and questionnaires (everyday functioning and psychological health) will be performed before training and directly after training and after 16 weeks. Patient expectation and measures of adherence (motivation and results during training) will be controlled for.
The iPARK trial is expected to provide novel and clinical useful information whether updating training is an effective training paradigm in PD. Further it will hopefully contribute to a better understanding of cognitive function in PD.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Parkinson's Disease (PD) is after Alzheimers disease (AD) the most common neurodegenerative disease with a prevalence of 1% of the population over 60 years of age. The cardinal symptoms are motoric and are believed to be caused by depletion of dopamine in the brain with severe depletion in the striatum. In addition to the motor impairments, there are several non-motor functions also affected, where cognitive decline and dementia are among the most common problems. Some claim that up to 75% of the total PD population will eventually develop dementia. Prior to dementia, milder cognitive problems are common and already at the time of diagnosis up to 42.5% of patients with PD are affected by decline in different cognitive functions. Early cognitive deficits seen is inhibition, shifting, working memory and planning, but a cognitive profile of visuospatial decline, semantic fluency and episodic memory has been connected to Parkinson's Disease Dementia (PDD). The occurrence of Lewy-bodies and Alzheimer type brain pathology is common in PDD but dopamine depletion has also been connected to cognitive decline in healthy elderly and in PD.
Although prescription of dementia medication in PD most likely has increased during the last decade there are limited evidence of treatment effects . This particular patient group is already burdened by polypharmacy and therefore investigating non-pharmacological interventions is of crucial importance. A recent systematic review of cognitive intervention studies in PD suggests that there is evidence of clinically meaningful improvements in overall cognition and moderate to large effect sizes on measures of working memory, processing speed and executive functions. Another review on the topic suggested that the results are promising, at least in the immediate or short term for some cognitive domains, but due to inconsistencies between studies and lack of methodological salience there are still a lot of questions unanswered. Baseline factors such as cognitive functioning, Hoehn and Yahr stage, premorbid intelligence all can have contributing effects on individual differences in training gain. Therefore it is important to thoroughly investigate baseline characteristics.
In the future, studies need to include more participants, be hypothesis driven and include more detail of the cognitive profile, training intervention and outcome measures.
One approach to cognitive training that has received a lot of attention and critique is process-based cognitive training, such as training focusing on working memory (WM) and executive functions (EF). The purpose of the process based approach is to strengthen general cognitive processes important to global cognitive functioning. WM and EF play central roles in several different functions such as episodic memory, reading comprehension and problem solving to mention a few. Research has also shown that WM and EF is negatively affected both in normal and pathological aging, such as PD.
Training of executive functioning and working memory have gained some promising results in healthy adults, showing improvements in working memory and executive functioning but there is also an indication of broader generalizations of training gain. Previously the effect of process-based updating training in healthy young and older individuals has been studied. Results showed that a period of updating training increased Blood Oxygen Level Dependent (BOLD) activity in striatum related to increased cognitive performance in both groups. Also a corresponding effect of training on dopaminergic neurotransmission was detected.
In the light of the dopamine dysfunction in PD, with negative effects on both motoric and cognitive function it is of interest to study if a non-invasive, non-pharmacological intervention can lead to better updating function with increased dopamine levels in patients with PD. The iPARK study is a double blinded randomized controlled trial that will examine the effect of a web-based cognitive training program with focus on updating training.
The primary question asked will be if updating training will improve the ability to update contents in working memory and also if there will be improvements in other cognitive functions such as psychomotor speed, working memory, executive functions and episodic memory. Further the aim is to investigate if there will be improvements in self-perceived everyday cognitive function and psychological health as well as if the effects seen will be sustained over a period of four months. Baseline factors will be investigated to see if they have a modulating effect on training. Further the iPARK trial will determine if a web-based training performed at home without active supervision is a feasible approach in this particular patient group. Compliance, adherence and expectations will be measured systematically.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anna S Neely, prof
- Phone Number: +46547001545
- Email: anna.neely@kau.se
Study Contact Backup
- Name: Magdalena E Domellöf, Phd
- Phone Number: +4690786 70 22
- Email: magdalena.domellof@umu.se
Study Locations
-
-
Västerbotten
-
Umea, Västerbotten, Sweden, 90187
- Recruiting
- Umeå University department of psychology
-
Contact:
- Magdalena E Domellöf, Phd
- Phone Number: +46907867022
- Email: magdalena.domellof@umu.se
-
Contact:
- Anna Stigsdotter Neely, Prof
- Phone Number: +46547001545
- Email: anna.neely@kau.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of Parkinson's Disease according to United Kingdom Parkinson's Disease Brain Bank (UKPDSBB) criteria
- Hoehn and Yahr stage I-III
- Pathological dat scan
- A score of 24 or over on the MMSE AND be without Dementia
- Stable medication over the past three months
- Owns and is able to use a home based computer or tablet with internet connection.
Exclusion Criteria:
- Unstable medication
- Ongoing cognitive training
- Diagnosis of PDD
- Drug or alcohol abuse
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Working memory updating training
Training with web-based program on the internet for 30 sessions (4-5 times a week). The result of the training is registered. Intervention Device: web-based cognitive training |
Each training session includes four working memory updating tasks that is performed at the participants home on their computer via internet.
Each training session takes about 20 minutes to perform.
Other Names:
|
Placebo Comparator: Placebo training
Low dose, short term memory training. Intervention: Training with computer based program on the internet for 30 sessions (4-5 times a week). Intervention Device: Web-based cognitive training |
Each training session includes four short term memory tasks that is performed at the participants home on their computer via internet.
Each training session takes about 20 minutes to perform.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Criterion task
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement on Letter memory after 30 sessions of working memory training.
total score:0-40 higher score indicate better performance total items:0-10 higher score indicate better performance
|
6-8 weeks (pretest-posttest 1)
|
Criterion task
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of Letter memory performance four months after completed working memory training. total score:0-40 higher score indicate better performance total items:0-10 higher score indicate better performance |
16 weeks (posttest 1-posttest 2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Transfer task n-back
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement on updating performance measured by n-back (1,2 and 3 back) after 30 sessions of working memory training.
1 back, Yes minus false alarms: 0-36 higher score indicate better performance 2 back, Yes minus false alarms: 0-36 higher score indicate better performance 3 back, Yes minus false alarms: 0-36 higher score indicate better performance |
6-8 weeks (pretest-posttest 1)
|
Transfer task n-back
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of updating performance measured by n-back (1,2 and 3 back) four months after completed working memory training.
1 back, Yes minus false alarms: 0-36 higher score indicate better performance 2 back, Yes minus false alarms: 0-36 higher score indicate better performance 3 back, Yes minus false alarms: 0-36 higher score indicate better performance |
16 weeks (posttest 1-posttest 2)
|
Transfer task digit memory running span
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement on updating performance measured by digit memory running span after 30 sessions of working memory training. total score:0-40 higher score indicate better performance total items:0-10 higher score indicate better performance |
6-8 weeks (pretest-posttest 1)
|
Transfer task digit memory running span
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of updating performance measured by digit memory running span four months after completed working memory training. total score:0-40 higher score indicate better performance total items:0-10 higher score indicate better performance |
16 weeks (posttest 1-posttest 2)
|
Updating total score
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement in calculated composite score based on z-score((raw test score-mean of group)/standard deviation of group) for digit memory running span, 2-back and 3-back. Range -4 to 4. Higher z-score indicate better updating performance. (z score(3back yes-false alarms)+z score(2back yes-false alarms)+z score (digit memory running span total))/3 |
6-8 weeks (pretest-posttest 1)
|
Updating total score
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of calculated composite score based on z-score((raw test score-mean of group)/standard deviation of group) for digit memory running span, 2-back and 3-back. Range -4 to 4. Higher z-score indicate better updating performance. (z score(3back yes-false alarms)+z score(2back yes-false alarms)+z score (digit memory running span total))/3 |
16 weeks (posttest 1-posttest 2)
|
Transfer task episodic memory
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement on episodic memory performance measured by Buschke Selective Reminding Procedure after 30 sessions of working memory training. total score: 0-74 higher score indicate better performance list learning: 0-74 delayed score:0-18 higher score indicate better performance |
6-8 weeks (pretest-posttest 1)
|
Transfer task episodic memory
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of on episodic memory performance measured by Buschke Selective Reminding Procedure four months after completed working memory training. total score: 0-74 higher score indicate better performance list learning: 0-74 higher score indicate better performance delayed score:0-18 higher score indicate better performance |
16 weeks (posttest 1-posttest 2)
|
Transfer task digit span
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement on working memory performance measured by Digit span forward, backwards and sequencing (WAIS IV) after 30 sessions of working memory training. digit span forward total score: 0-16 higher score indicate better performance digit span backwards total score: 0-16 higher score indicate better performance digit span sequencing total score:0-16 higher score indicate better performance |
6-8 weeks (pretest-posttest 1)
|
Transfer task digit span
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of working memory performance measured by Digit span forward, backwards and sequencing (WAIS IV) after 30 sessions of working memory training. digit span forward total score: 0-16 higher score indicate better performance digit span backwards total score: 0-16 higher score indicate better performance digit span sequencing total score:0-16 higher score indicate better performance |
16 weeks (posttest 1-posttest 2)
|
Transfer task visuospatial-span
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Maintenance of visuospatial working memory performance measured by visuospatial span task, 0-18 higher score indicate better performance
|
6-8 weeks (pretest-posttest 1)
|
Transfer task visuospatial-span
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of visuospatial working memory performance measured by visuospatial span task, total score 0-18 higher score indicate better performance
|
16 weeks (posttest 1-posttest 2)
|
working memory total score
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement in calculated composite score based on z-score((raw test score-mean of group)/standard deviation of group) from digit span forward, digit span backward, digit span sequencing and visuospatial span task, higher score indicate better performance Range -4 to 4. (z score(digit span forward)+z score(digit span backward)+z score (digit span sequencing)+z score (visuospatial span task))/4 |
6-8 weeks (pretest-posttest 1)
|
working memory total score
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance in calculated composite score based on z-score((raw test score-mean of group)/standard deviation of group) from digit span forward, digit span backward, digit span sequencing and visuospatial span task, higher score indicate better performance. Range -4 to 4. (z score(digit span forward)+z score(digit span backward)+z score (digit span sequencing)+z score (visuospatial span task))/4 |
16 weeks (posttest 1-posttest 2)
|
Transfer task Matrices (WAIS IV)
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement on problem solving performance measured by Matrices (WAIS IV) after 30 sessions of working memory training. total score: 0-26, higher score indicate better performance |
6-8 weeks (pretest-posttest 1)
|
Transfer task Matrices (WAIS IV)
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of problem solving performance measured by Matrices (WAIS IV) after 30 sessions of working memory training. total score: 0-26, higher score indicate better performance |
16 weeks (posttest 1-posttest 2)
|
Transfer task Digit symbol
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement on mental and psychomotor speed measured by Digit symbol after 30 sessions of working memory training. total score: 0-135, higher score indicate better performance |
6-8 weeks (pretest-posttest 1)
|
Transfer task Digit symbol
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of mental and psychomotor speed measured by Digit symbol four months after completed working memory training. total score: 0-135, higher score indicate better performance |
16 weeks (posttest 1-posttest 2)
|
Transfer task Perdue pegboard
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement in calculated mental and psychomotor speed measured by Perdue pegboard after 30 sessions of working memory training. total score right hand: 0-24, higher score indicate better performance total score left hand: 0-24 higher score indicate better performance total score both hands: 0-24higher score indicate better performance |
6-8 weeks (pretest-posttest 1)
|
Transfer task Perdue pegboard
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of mental and psychomotor speed measured by Perdue pegboard four months after completed working memory training. total score right hand: 0-24, higher score indicate better performance total score left hand: 0-24 higher score indicate better performance total score both hands: 0-24higher score indicate better performance |
16 weeks (posttest 1-posttest 2)
|
Mental and psychomotor speed total score
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement in calculated composite score based on z-score((raw test score-mean of group)/standard deviation of group) for Digit symbol and Perdue pegboard after 30 sessions of working memory training. higher score indicate better performance (range -4 to 4). (z score(Perdue pegboard)+z score(digit symbol))/2 |
6-8 weeks (pretest-posttest 1)
|
Mental and psychomotor speed total score
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of calculated composite score based on z-score((raw test score-mean of group)/standard deviation of group) from Digit symbol and Perdue pegboard four months after completed working memory training. higher score indicate better performance. (range -4 to 4). (z score(Perdue pegboard)+z score(digit symbol))/2 |
16 weeks (posttest 1-posttest 2)
|
Transfer task Stroop test
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement of executive functions measured by Stroop test (DKEFS) after 30 sessions of working memory training. color naming 0-90 seconds less time indicate better performance word naming 0-90 seconds less time indicate better performance inhibition 0-90 seconds less time indicate better performance Inhibition cost total score:0-90 seconds, less inhibition cost indicate better performance |
6-8 weeks (pretest-posttest 1)
|
Transfer task Stroop test
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of executive functions measured by Stroop test (DKEFS) four months after completed working memory training. color naming 0-90 seconds less time indicate better performance word naming 0-90 seconds less time indicate better performance inhibition 0-90 seconds less time indicate better performance Inhibition cost total score:0-90 seconds, less inhibition cost indicate better performance |
16 weeks (posttest 1-posttest 2)
|
Transfer task Trail Making Test
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement on executive functions measured by Trail Making Test A and B (DKEFS) after 30 sessions of working memory training. TMT A 0-250 seconds less time indicate better performance TMT B 0-350 seconds less time indicate better performance Shift cost (TMTB-TMTA): 0-200 seconds, less shift cost indicate better performance |
6-8 weeks (pretest-posttest 1)
|
Transfer task Trail Making Test
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of executive functions measured by Trail Making Test A and B (DKEFS) four months after completed working memory training. TMT A 0-250 seconds less time indicate better performance TMT B 0-350 seconds less time indicate better performance Shift cost (TMTB-TMTA): 0-200 seconds, less shift cost indicate better performance |
16 weeks (posttest 1-posttest 2)
|
Executive function total score
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement calculated composite score based on z-score((raw test score-mean of group)/standard deviation of group) of Stroop test and Trail Making Test A and B after 30 sessions of working memory training higher score indicate better performance. Range -4 to 4. (z score(-TMTB-TMTA)+z score(-inhibition cost))/2 |
6-8 weeks (pretest-posttest 1)
|
Executive function total score
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of calculated z-score ((raw test score-mean of group)/standard deviation of group) of Stroop test and Trail Making Test A and B after 30 sessions of working memory training higher score indicate better performance. Range -4 to 4. (z score(-TMTB-TMTA)+z score(-inhibition cost))/2 |
16 weeks (posttest 1-posttest 2)
|
Transfer task subjective cognitive complaints
Time Frame: 6-8 weeks (pretest-posttest 1)
|
Improvement on subjective memory complaints measured by Prospective retrospective memory questionaire after 30 sessions of working memory training. total score: 16-80 higher scores indicate more cognitive complaints prospective score: 0-100 higher scores indicate more cognitive complaints retrospective score: 0-100 higher scores indicate more cognitive complaints short term score: 0-100 higher scores indicate more cognitive complaints long term score: 0-100 higher scores indicate more cognitive complaints self cued score: 0-100 higher scores indicate more cognitive complaints environmentally cued: 0-100 higher scores indicate more cognitive complaints |
6-8 weeks (pretest-posttest 1)
|
Transfer task subjective cognitive complaints
Time Frame: 16 weeks (posttest 1-posttest 2)
|
Maintenance of subjective memory complaints measured by Prospective retrospective memory questionaire four months after completed working memory training.total
score: 16-80 higher scores indicate more cognitive complaints prospective score: 0-100 higher scores indicate more cognitive complaints retrospective score: 0-100 higher scores indicate more cognitive complaints short term score: 0-100 higher scores indicate more cognitive complaints long term score: 0-100 higher scores indicate more cognitive complaints self cued score: 0-100 higher scores indicate more cognitive complaints environmentally cued: 0-100 higher scores indicate more cognitive complaints
|
16 weeks (posttest 1-posttest 2)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital Anxiety Depression scale (Depression and anxiety)
Time Frame: 6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Severity of depression and anxiety symptoms measured by Hospital Anxiety Depression scale Anxiety score: 0-21 higher score indicate more anxiety Depression score: 0-21 higher score indicate more depression
|
6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Short Form Health Survey sf-36 (Health status)
Time Frame: 6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Health status measured by the Short Form Health Survey (sf-36) physical functioning score: 0-100 higher scores indicate less problems role limitations score: 0-100 higher scores indicate less problems energy fatigue score: 0-100 higher scores indicate less problems emotional well being score: 0-100 higher scores indicate less problems social functioning score: 0-100 higher scores indicate less problems pain score: 0-100 higher scores indicate less problems general health: 0-100 higher scores indicate less problems
|
6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Short version of the Karolinska Sleep Questionnaire (Sleep status)
Time Frame: 6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Sleep status measured by the Short version of the Karolinska Sleep Questionnaire total score: 5-30 higher scores indicate better sleep
|
6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Parkinson's Disease Questionnaire PDQ-39 (Function and well being)
Time Frame: 6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Function and well being measured by Parkinson's Disease Questionnaire-39 (PDQ39) Mobility score: 0-100 higher scores indicate more problems Activity of Daily Living score: 0-100 higher scores indicate more problems Emotional well being score: 0-100 higher scores indicate more problems Stigma score: 0-100 higher scores indicate more problems Social support score: 0-100 higher scores indicate more problems Cognition score: 0-100 higher scores indicate more problems Communication score: 0-100 higher scores indicate more problems Bodily discomfort score: 0-100 higher scores indicate more problems Summary index: 0-100 higher scores indicate more problems
|
6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Urgency, Premeditation, Perseverance and Sensation Seeking Questionnaire UPPS (Impulsivity and risk taking)
Time Frame: 6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Impulsivity and risk taking measured by Urgency, Premeditation, Perseverance and Sensation Seeking Questionnaire (UPPS) Urgency score: 0-100 higher score indicate more urgency Premeditation score:0-100 higher score indicate less premeditation Perseverance score: 0-100 higher score indicate less perseverance Sensation seeking score: 0-100 higher score indicate more sensation seeking.
|
6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Balloon Analogue Risk Taking Task BART (Impulsivity and risk taking)
Time Frame: 6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Impulsivity and risk taking measured by the Balloon Analogue Risk Taking Task (BART). Number of explosions: 0-30 |
6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Checklist Individual Strength Questionnaire CIS (Fatigue)
Time Frame: 6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Fatigue measured by Checklist Individual Strength Questionnaire (CIS) after 30 sessions of working memory training. total score: 20-140 |
6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Adherence (Task engagement)
Time Frame: 6-8 weeks (during training)
|
Task engagement is measured by self assessed motivation to training and ability to stay focused during training measured before and after each training session.
|
6-8 weeks (during training)
|
Compliance (Finishing training within time frame)
Time Frame: 6-8 weeks (during training)
|
Compliance is measured by number of participants finishing the training within time frame, 6-8 weeks.
|
6-8 weeks (during training)
|
Age
Time Frame: before training (pretest)
|
Demographic characteristic: age at baseline
|
before training (pretest)
|
sex
Time Frame: before training (pretest)
|
Demographic characteristic: sex
|
before training (pretest)
|
Educational level
Time Frame: before training (pretest)
|
Demographic characteristic: educational level
|
before training (pretest)
|
Disease duration
Time Frame: before training (pretest)
|
Demographic characteristic: disease duration
|
before training (pretest)
|
Disease stage
Time Frame: before training (pretest)
|
Disease characteristic: disease stage (Hoehn and Yahr stage) Range 0-4
|
before training (pretest)
|
Levodopa Equivalent Dose (Medication for Parkinson's Disease)
Time Frame: 6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Medication use measured by Levodopa Equivalent Dose
|
6-8 weeks (pretest- posttest 1) 16 weeks (posttest 1 - posttest 2)
|
Unified Parkinson's Disease Rating Scale (Motor symptoms)
Time Frame: before training (pretest)
|
Motor symptoms assessed by the Unified Parkinson's Disease Rating Scale part 3 Total score:0-108 (higher scores indicate more motor symptoms)
|
before training (pretest)
|
Mini Mental State Examination (Global cognitive function)
Time Frame: before training (pretest)
|
Global cognitive function measured by Mini Mental State Examination (MMSE) Total score: 24-30 (patients with lower scores is not included), lower scores indicate worse performance.
|
before training (pretest)
|
Side (left or right) most affected of Parkinson's Disease symptoms
Time Frame: before training (pretest)
|
Disease characteristic: Most affected and starting side (Parkinsons symptoms)
|
before training (pretest)
|
Swedish vocabulary test SRB (Verbal ability)
Time Frame: before training (pretest)
|
Verbal ability measured by Swedish vocabulary test (SRB).
total score: 0-30 higher scores indicate better performance
|
before training (pretest)
|
Incidence of Treatment-Emergent Adverse Events (Safety and tolerability)
Time Frame: 6-8 weeks (during training and at post test)
|
All adverse events connected to training reported from participants and/or family members throughout the training period and after training are registered.
|
6-8 weeks (during training and at post test)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Anna S Neely, Prof, Karlstad University
Publications and helpful links
General Publications
- Dahlin E, Neely AS, Larsson A, Backman L, Nyberg L. Transfer of learning after updating training mediated by the striatum. Science. 2008 Jun 13;320(5882):1510-2. doi: 10.1126/science.1155466.
- Chein JM, Morrison AB. Expanding the mind's workspace: training and transfer effects with a complex working memory span task. Psychon Bull Rev. 2010 Apr;17(2):193-9. doi: 10.3758/PBR.17.2.193.
- Dahlin E, Nyberg L, Backman L, Neely AS. Plasticity of executive functioning in young and older adults: immediate training gains, transfer, and long-term maintenance. Psychol Aging. 2008 Dec;23(4):720-30. doi: 10.1037/a0014296.
- Klingberg T. Training and plasticity of working memory. Trends Cogn Sci. 2010 Jul;14(7):317-24. doi: 10.1016/j.tics.2010.05.002. Epub 2010 Jun 16.
- de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006 Jun;5(6):525-35. doi: 10.1016/S1474-4422(06)70471-9.
- Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. Mov Disord. 2011 Oct;26 Suppl 3(0 3):S42-80. doi: 10.1002/mds.23884.
- Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson disease. J Neurol Sci. 2010 Feb 15;289(1-2):18-22. doi: 10.1016/j.jns.2009.08.034. Epub 2009 Sep 4.
- Elgh E, Domellof M, Linder J, Edstrom M, Stenlund H, Forsgren L. Cognitive function in early Parkinson's disease: a population-based study. Eur J Neurol. 2009 Dec;16(12):1278-84. doi: 10.1111/j.1468-1331.2009.02707.x. Epub 2009 Jun 15.
- Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O'Brien JT, Robbins TW, Wesnes K, Brooks DJ, Barker RA, Burn DJ; ICICLE-PD Study Group. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology. 2014 Jan 28;82(4):308-16. doi: 10.1212/WNL.0000000000000066. Epub 2013 Dec 20.
- Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol. 2010 Dec;9(12):1200-1213. doi: 10.1016/S1474-4422(10)70212-X. Epub 2010 Sep 27.
- Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ. Striatal dopamine and working memory. Cereb Cortex. 2009 Feb;19(2):445-54. doi: 10.1093/cercor/bhn095. Epub 2008 Jun 11.
- Ekman U, Eriksson J, Forsgren L, Mo SJ, Riklund K, Nyberg L. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study. Lancet Neurol. 2012 Aug;11(8):679-87. doi: 10.1016/S1474-4422(12)70138-2. Epub 2012 Jun 27. Erratum In: Lancet Neurol. 2012 Nov;11(11):934.
- Ito K, Nagano-Saito A, Kato T, Arahata Y, Nakamura A, Kawasumi Y, Hatano K, Abe Y, Yamada T, Kachi T, Brooks DJ. Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study. Brain. 2002 Jun;125(Pt 6):1358-65. doi: 10.1093/brain/awf134. Erratum In: Brain 2002 Sep;125(Pt 9):2144.
- Leung IH, Walton CC, Hallock H, Lewis SJ, Valenzuela M, Lampit A. Cognitive training in Parkinson disease: A systematic review and meta-analysis. Neurology. 2015 Nov 24;85(21):1843-51. doi: 10.1212/WNL.0000000000002145. Epub 2015 Oct 30.
- Glizer D, MacDonald PA. Cognitive Training in Parkinson's Disease: A Review of Studies from 2000 to 2014. Parkinsons Dis. 2016;2016:9291713. doi: 10.1155/2016/9291713. Epub 2016 Sep 5.
- Morrison AB, Chein JM. Does working memory training work? The promise and challenges of enhancing cognition by training working memory. Psychon Bull Rev. 2011 Feb;18(1):46-60. doi: 10.3758/s13423-010-0034-0.
- Shipstead Z, Redick TS, Engle RW. Is working memory training effective? Psychol Bull. 2012 Jul;138(4):628-654. doi: 10.1037/a0027473. Epub 2012 Mar 12.
- Unsworth N, Engle RW. Simple and complex memory spans and their relation to fluid abilities: Evidence from list-length effects. Journal of Memory and Language 54(1): 68-80, 2006.
- Unsworth N, Engle RW. The nature of individual differences in working memory capacity: active maintenance in primary memory and controlled search from secondary memory. Psychol Rev. 2007 Jan;114(1):104-32. doi: 10.1037/0033-295X.114.1.104.
- Gabrieli JDE, Singh J, Stebbins GT, & Goetz CG. Reduced working memory span in Parkinson's disease: Evidence for the role of frontostriatal system in working and strategic memory. Neuropsychology, 10(3): 322-332,1996.
- McCabe DP, Roediger HL, McDaniel MA, Balota DA, Hambrick DZ. The relationship between working memory capacity and executive functioning: evidence for a common executive attention construct. Neuropsychology. 2010 Mar;24(2):222-243. doi: 10.1037/a0017619.
- Backman L, Nyberg L, Soveri A, Johansson J, Andersson M, Dahlin E, Neely AS, Virta J, Laine M, Rinne JO. Effects of working-memory training on striatal dopamine release. Science. 2011 Aug 5;333(6043):718. doi: 10.1126/science.1204978.
- Backman L, Waris O, Johansson J, Andersson M, Rinne JO, Alakurtti K, Soveri A, Laine M, Nyberg L. Increased dopamine release after working-memory updating training: Neurochemical correlates of transfer. Sci Rep. 2017 Aug 2;7(1):7160. doi: 10.1038/s41598-017-07577-y.
- Domellof ME, Walton L, Boraxbekk CJ, Backstrom D, Josefsson M, Forsgren L, Stigsdotter Neely A. Evaluating a frontostriatal working-memory updating-training paradigm in Parkinson's disease: the iPARK trial, a double-blinded randomized controlled trial. BMC Neurol. 2020 Sep 7;20(1):337. doi: 10.1186/s12883-020-01893-z.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- dnr 2014-1654
- dnr 2017-02371 (Other Grant/Funding Number: The Swedish Research Council)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Working memory updating training
-
Henry Ford Health SystemNot yet recruiting
-
University of GeorgiaRecruitingSchizophrenia | Schizo Affective DisorderUnited States
-
Milwaukee VA Medical CenterCompletedPosttraumatic Stress DisorderUnited States
-
Radboud University Medical CenterNetherlands Organisation for Scientific ResearchCompletedAttention Deficit Disorder With HyperactivityNetherlands
-
Norwegian University of Science and TechnologyCompletedInfant, Very Low Birth WeightNorway
-
St. Jude Children's Research HospitalAmerican Cancer Society, Inc.CompletedAcute Lymphoblastic Leukemia | Brain TumorUnited States
-
Centre d'Investigation Clinique et Technologique...UnknownCognitive Impairment | Traumatic Brain InjuryFrance
-
University of CalgaryWithdrawn
-
University of MichiganRecruiting
-
University of WaterlooCompleted